[Ventriculography and cervical myelography with amipak (metrizamide)].
The authors analyse the results of examination of 96 patients with administration of a new water-soluble radiopaque medium amipak (metrisamide) into the ventricles of the brain (22 cases) and subarachnoid space of the spinal cord (74 cases). The best results were obtained in the diagnosis of Schmorl's body in the cervical spinal segment and in location of new growths in the posterior cranial fossa and those of supratentorial and intraventricular localization. Convincing diagnostic signs of the level of CSF communications obstruction were obtained. EEG was performed in 54 patients. The possible vegetative reactions to amipak injection are described. Amipak possesses minimum toxicity and good radiopacity.
D001368:Axis, Cervical Vertebra / Q000293:injuries; D014695:Cerebral Ventriculography; D050723:Fractures, Bone / Q000000981:diagnostic imaging; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging*; D008793:Metrizamide; D009192:Myelography; D013116:Spinal Cord / Q000098:blood supply; D013118:Spinal Cord Diseases / Q000000981:diagnostic imaging*; D013120:Spinal Cord Neoplasms / Q000000981:diagnostic imaging; D014652:Vascular Diseases / Q000000981:diagnostic imaging
D008793:Metrizamide
Ventrikulografiia i sheĭnaia mielografiia s amipakom (metrizamidom).